Literature DB >> 20133360

Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis.

Tetsuro Morinaga1, Hitoshi Ashida, Ken-ichi Yoshida.   

Abstract

scyllo-Inositol (SI) is a stereoisomer of inositol whose catabolism has not been characterized in bacteria. We found that Bacillus subtilis 168 was able to grow using SI as its sole carbon source and that this growth was dependent on a functional iol operon for catabolism of myo-inositol (MI; another inositol isomer, which is abundant in nature). Previous studies elucidated the MI catabolic pathway in B. subtilis as comprising multiple stepwise reactions catalysed by a series of Iol enzymes. The first step of the pathway converts MI to scyllo-inosose (SIS) and involves the MI dehydrogenase IolG. Since IolG does not act on SI, we suspected that there could be another enzyme converting SI into SIS, namely an SI dehydrogenase. Within the whole genome, seven genes paralogous to iolG have been identified and two of these, iolX and iolW (formerly known as yisS and yvaA, respectively), were selected as candidate genes for the putative SI dehydrogenase since they were both prominently expressed when B. subtilis was grown on medium containing SI. iolX and iolW were cloned in Escherichia coli and both were shown to encode a functional enzyme, revealing the two distinct SI dehydrogenases in B. subtilis. Since inactivation of iolX impaired growth with SI as the carbon source, IolX was identified as a catabolic enzyme required for SI catabolism and it was shown to be NAD(+) dependent. The physiological role of IolW remains unclear, but it may be capable of producing SI from SIS with NADPH oxidation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133360     DOI: 10.1099/mic.0.037499-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  11 in total

1.  Inositol catabolism, a key pathway in sinorhizobium meliloti for competitive host nodulation.

Authors:  Petra R A Kohler; Jasmine Y Zheng; Elke Schoffers; Silvia Rossbach
Journal:  Appl Environ Microbiol       Date:  2010-10-22       Impact factor: 4.792

2.  The RpiR-like repressor IolR regulates inositol catabolism in Sinorhizobium meliloti.

Authors:  Petra R A Kohler; Ee-Leng Choong; Silvia Rossbach
Journal:  J Bacteriol       Date:  2011-07-22       Impact factor: 3.490

3.  An L-glucose catabolic pathway in Paracoccus species 43P.

Authors:  Tetsu Shimizu; Naoki Takaya; Akira Nakamura
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

4.  A second-generation Bacillus cell factory for rare inositol production.

Authors:  Kosei Tanaka; Shinji Takanaka; Ken-ichi Yoshida
Journal:  Bioengineered       Date:  2014 Sep-Oct       Impact factor: 3.269

5.  Mining the Sinorhizobium meliloti transportome to develop FRET biosensors for sugars, dicarboxylates and cyclic polyols.

Authors:  Alexandre Bourdès; Steven Rudder; Alison K East; Philip S Poole
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

6.  A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease.

Authors:  Masaru Yamaoka; Shin Osawa; Tetsuro Morinaga; Shinji Takenaka; Ken-ichi Yoshida
Journal:  Microb Cell Fact       Date:  2011-09-07       Impact factor: 5.328

7.  Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD+-dependent scyllo-inositol dehydrogenase.

Authors:  Dong-Min Kang; Christophe Michon; Tetsuro Morinaga; Kosei Tanaka; Shinji Takenaka; Shu Ishikawa; Ken-Ichi Yoshida
Journal:  BMC Microbiol       Date:  2017-07-11       Impact factor: 3.605

8.  A bacterial cell factory converting glucose into scyllo-inositol, a therapeutic agent for Alzheimer's disease.

Authors:  Christophe Michon; Choong-Min Kang; Sophia Karpenko; Kosei Tanaka; Shu Ishikawa; Ken-Ichi Yoshida
Journal:  Commun Biol       Date:  2020-03-02

9.  An improved Bacillus subtilis cell factory for producing scyllo-inositol, a promising therapeutic agent for Alzheimer's disease.

Authors:  Kosei Tanaka; Shintaro Tajima; Shinji Takenaka; Ken-ichi Yoshida
Journal:  Microb Cell Fact       Date:  2013-12-11       Impact factor: 5.328

10.  A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production.

Authors:  Kosei Tanaka; Ayane Natsume; Shu Ishikawa; Shinji Takenaka; Ken-Ichi Yoshida
Journal:  Microb Cell Fact       Date:  2017-04-21       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.